Reviews
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Creative Biolabs
"Anti-CD22 (Pinatuzumab) h(CD28-CD3_) CAR, Jurkat Cell" | Creative Biolabs
The anti-CD22 chimeric antigen receptor (CAR) Jurkat cell line is a stable cell line derived from anti-CD22 CAR lentivirus transduction. This transduced CAR lentiviral vector was constructed to express scFv of an anti-CD22 antibody linked to the CD28 and CD3_ signaling domains. And this recombinant cell product can be used to target human CD22 and treat Acute lymphoblastic leukemia (ALL).
Supporting Documents
Data Sheet
Datasheet
More Scientific Products from Creative Biolabs
![Anti-PRAME antibody [EPR20330]](https://d3bkbkx82g74b8.cloudfront.net/eyJidWNrZXQiOiJsYWJyb290cy1pbWFnZXMiLCJrZXkiOiJjb21wYW55X3Byb2R1Y3RfcHJvZmlsZV9pbWFnZV9mMzEwNTY4MGY1NmVmZjU3ZjZhMWRkZTU2M2Q4YjBmODZjMDJkNDE4XzMwMDA3MTg1ODEyLmpwZyIsImVkaXRzIjp7InRvRm9ybWF0IjoianBnIiwicmVzaXplIjp7IndpZHRoIjozMDAsImhlaWdodCI6MzAwLCJmaXQiOiJjb3ZlciIsInBvc2l0aW9uIjoiY2VudGVyIiwiYmFja2dyb3VuZCI6IiNmZmYifSwiZmxhdHRlbiI6eyJiYWNrZ3JvdW5kIjoiI2ZmZiJ9fX0=)
-
OCT 15, 2025Cell & Gene Therapy Virtual Event Series 2025 -
OCT 15, 2025xMAP Connect 2025 Virtual Series
-
OCT 22, 2025CRISPR Virtual Event Series 2025
-
OCT 27, 202568th Annual Biosafety and Biosecurity Conference
-
NOV 04, 2025The Simple Way to Protein Research
- See More
Opens in a new window
Opens an external site
Opens an external site in a new window